Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment

The myeloma bone marrow microenvironment promotes proliferation of malignant plasma cells and resistance to therapy. Activation of JAK/STAT signaling is thought to be a central component of these microenvironment-induced phenotypes. In a prior drug repurposing screen, we identified tofacitinib, a pa...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Christine Lam, Ian D. Ferguson, Margarette C. Mariano, Yu-Hsiu T. Lin, Megan Murnane, Hui Liu, Geoffrey A. Smith, Sandy W. Wong, Jack Taunton, Jun O. Liu, Constantine S. Mitsiades, Byron C. Hann, Blake T. Aftab, Arun P. Wiita
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Ferrata Storti Foundation 2018-07-01
Colecção:	Haematologica
Acesso em linha:	https://haematologica.org/article/view/8526
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!